ZHUANG SANTACANA: Open Payments
NPI 1265971642 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,638 in 87 payments from 18 companies in 2025. Trend: 2023 $1,847 · 2024 $1,416 · 2025 $1,638
Food & beverage: $1,619Education: $19
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 16 | $309 |
| Medtronic, Inc. | 16 | $226 |
| BETA BIONICS, INC. | 6 | $203 |
| Insulet Corporation | 8 | $170 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $142 |
| Dexcom, Inc. | 5 | $102 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $83 |
| Amgen Inc. | 4 | $73 |
| Tandem Diabetes Care, Inc. | 4 | $68 |
| Lilly USA, LLC | 3 | $51 |
Products named: MINIMED 780G, iLet Bionic Pancreas, Omnipod, Rybelsus, JARDIANCE, Ozempic, Dexcom G6 Transmitter, Kerendia.
Industry payments across IN — which companies pay providers there.
